Reduction of microRNA-184 by E6 oncoprotein confers cisplatin resistance in lung cancer via increasing Bcl-2

MicroRNA-184 suppresses cell growth and survival via targeting c-Myc and Bcl- 2. We recently reported that miR-184 promotes tumor progression in non-small cell lung cancer via targeting CDC25A and c-Myc. We here hypothesized that miR-184 could be down-regulated by E6 oncoprotein to confer cisplatin...

Descripción completa

Detalles Bibliográficos
Autores principales: Tung, Min-Che, Lin, Po-Lin, Cheng, Ya-Wen, Wu, De-Wei, Yeh, Sauh-Der, Chen, Chi-Yi, Lee, Huei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078019/
https://www.ncbi.nlm.nih.gov/pubmed/27083050
http://dx.doi.org/10.18632/oncotarget.8708

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078019/
https://www.ncbi.nlm.nih.gov/pubmed/27083050
http://dx.doi.org/10.18632/oncotarget.8708

Ejemplares similares